Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 62.63MTotal Assets
VS
Market
Sector
Industry
History
$ 2.02Close
$ 1.52 - $ 4.62 52-Week Range
Ticker Information
Ticker
MREOCompany Name
MEREO BIOPHARMA GROUP PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMEREO BIOPHARMA GROUP PLC - Total Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MREO - Assets Historical data
| Date | Total Assets |
|---|---|
| 6/30/2025 | $ 62.63M |
| 3/31/2025 | $ 68.32M |
| 12/31/2024 | $ 76.39M |
| 9/30/2024 | $ 88.75M |
| 6/30/2024 | $ 96.13M |
| 3/31/2024 | $ 55.94M |
| 12/31/2023 | $ 66.5M |
| 6/30/2023 | $ 100.8M |
| 12/31/2022 | $ 110.1M |
| 6/30/2022 | $ 135.04M |
Key Performance Insights, Last 5 Years
- MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) Assets stands at $ 78.68M.
- Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average Assets has been $ 98.34M.
- The median Assets for MEREO BIOPHARMA GROUP PLC during this period was $ 88.75M
- MEREO BIOPHARMA GROUP PLC reached its highest Assets over the past 5 years at $ 181.15M.
- The lowest Assets recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe $ 55.94M
MEREO BIOPHARMA GROUP PLC's Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets Benchmarks
Similar metrics to Assets:
- Gross Profits to Assets - [Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Non-Current Assets - [Balance Sheet] The non-current (long-term) portion of [Assets] that are not easily converted to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
Definition of Total Assets
[Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.MREO - Total Assets, Last 5 years
$ 55.94M
Minimum
Mar 31, 2024
$ 181.15M
Maximum
Jun 30, 2021
$ 98.34M
Average
$ 88.75M
Median
Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Assets for companies in the Total Stock Market. The average Assets of the companies is $ 1.32B with a standard deviation of $ 1.71B.
The following table provides additional summary stats:
Assets in the Market:
| filtered constituents | 3.48K |
|---|---|
| min | $ 0 |
| max | $ 6.99B |
| average | $ 1.32B |
| median | $ 496.64M |
| std | $ 1.71B |